Myriad Genetics (NASDAQ:MYGN) Q3 2026 Earnings Call
Myriad Genetics (NASDAQ:MYGN) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Myriad Genetics, Inc. (NASDAQ:MYGN)
- Period
- Q3 2026 earnings call
- Date
- Wed, Nov 4, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/myriad-genetics-inc-mygn-q3-2026-earnings-call
Latest news releases
- NASDAQ:MYGN — Myriad Genetics Releases New MONSTAR-SCREEN-3 Data Demonstrating the Potential of Ultra-Sensitive MRD Detection in Colorectal and Pancreatic Cancers · Thu, Oct 22, 2026
- NASDAQ:MYGN — Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp · Tue, Oct 20, 2026